NASDAQ:RKDA Arcadia Biosciences Q1 2026 Earnings Report $0.89 -0.01 (-1.55%) As of 12:33 PM Eastern ProfileEarnings HistoryForecast Arcadia Biosciences EPS ResultsActual EPS-$2.11Consensus EPS -$0.80Beat/MissMissed by -$1.31One Year Ago EPSN/AArcadia Biosciences Revenue ResultsActual Revenue$1.10 millionExpected Revenue$1.60 millionBeat/MissMissed by -$500.00 thousandYoY Revenue GrowthN/AArcadia Biosciences Announcement DetailsQuarterQ1 2026Date5/14/2026TimeBefore Market OpensConference Call DateThursday, May 14, 2026Conference Call Time4:00PM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Arcadia Biosciences Earnings HeadlinesArcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business HighlightsMay 15, 2026 | markets.businessinsider.comArcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business HighlightsMarch 26, 2026 | markets.businessinsider.comThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.May 22 at 1:00 AM | Behind the Markets (Ad)Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business HighlightsMarch 26, 2026 | globenewswire.comArcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross ProceedsJanuary 12, 2026 | globenewswire.comRKDA stock rises pre-market after company receives merger termination notice from Roosevelt ResourcesDecember 26, 2025 | msn.comSee More Arcadia Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email. Email Address About Arcadia BiosciencesArcadia Biosciences (NASDAQ:RKDA), founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA. Arcadia’s operations span two main segments: Crop Traits and Food Ingredients. The Crop Traits division develops seed traits such as drought tolerance, salt tolerance, and enhanced oil or fiber profiles, which are licensed to major seed companies for integration into commercial seed offerings. The Food Ingredients division leverages specialty crops to produce plant-based ingredients—including high-fiber wheat, functional starches, and plant proteins—targeted at food and beverage manufacturers seeking clean-label, nutritionally improved solutions. To advance its pipeline and broaden its geographic footprint, Arcadia collaborates with global agricultural partners, research institutions, and development agencies. The company conducts field trials and pilot programs across North America, Australia, and Latin America, adapting its trait technologies to diverse agronomic conditions. With a commitment to environmental stewardship, Arcadia aims to reduce inputs such as water and synthetic fertilizers, thereby supporting sustainable agricultural practices. Through strategic alliances and a diversified portfolio, Arcadia Biosciences works to address global food security challenges and meet the growing consumer demand for healthier, more sustainable foods.View Arcadia Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Overextended, e.l.f. Beauty Is Primed to Rebound in Back HalfDeere Beats Q2 Estimates, But Ag Weakness Weighs on OutlookNVIDIA Price Pullback? Don’t Count on It, Business Is AcceleratingMeta Platforms 10% Layoff Raises a Bigger Question About AI SpendingBiogen Stock Slides After Trial Miss, But Analysts Stay BullishTarget Shows Strengths, But Analysts Want to See MoreLowe's Finds Support at $215 After Q1 Earnings Sell-Off Upcoming Earnings AutoZone (5/26/2026)Marvell Technology (5/27/2026)PDD (5/27/2026)Synopsys (5/27/2026)Bank Of Montreal (5/27/2026)Bank of Nova Scotia (5/27/2026)Salesforce (5/27/2026)Snowflake (5/27/2026)Autodesk (5/28/2026)Costco Wholesale (5/28/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
